About CytoTrack

CytoTrack ApS was established in 2004, and the first product was released on the market in 2011.

CytoTrack is an affiliated company of the engineering consultancy 2C A/S.

Management

Tom Hede Markussen, PhD CEO (Chief Executive Officer) and Founder
Henrik Stender, PhD CCO (Chief Clinical Officer)

Board

Lars Marcus Pedersen (Chairman, Attorney)
Christian Caspersen (Founder)
Lars Ulrik Nielsen (Founder, CEO of 2C A/S)

IPR

The CytoTrack technology is patented.

History

The technology was invented at a research development project at The National Hospital of Denmark. The project was headed by Professor John Philip.The application was to identify FCMB (Fetal Cells in Maternal Blood).

This project discovered that conventional instruments such as flowcytometry and common fluorescent scanners were not useful for this type of applications in order to detect the extreme rare fetal cells and for molecular characterization.

The CytoTrack technology was invented and developed specifically for the challenges of rare cell detection by Christian Caspersen. Other applications such as detection of CTCs was soon adopted.

In 2004, the first recognized paper about CTCs were published in The New England Journal of Medicine. This paper was the first to demonstrate the clinical value of enumeration of CTCs. Since then, CytoTrack has developed and optimized the CytoTrack technology to show breakthrough performance within the CTC application.

In 2011, CytoTrack has commercially released the CytoTrack technology.

In 2015, CytoTrack launched the CT11™ system incorporating cell picking from the disc.

Become a CytoTrack Agent or Distributor

CytoTrack is currently expanding the sales activities on new markets and market segments (US and Europe).

We search for distribution companies or agencies with a longstanding, committed presence in a specific region or market segment.

CytoTrack customers include life science research facilities and laboratories, large and small pharmaceutical companies and innovative cancer research labs.

If you are interested in learning more about distribution opportunities with CytoTrack in order to serve the needs of current and future CytoTrack end users, please send us an email

Send email

Service, training and support

For more than 10 years, CytoTrack ApS and its affiliated engineering company 2C A/S has been spacialized in design, development and maintenance of specialized rare cell detection systems. This in-depth knowledge and experience is available to customers through comprehensive training, application and technical support and expert field service.

Hotline service

CytoTrack offer a hotline service for customers.